Disease Screening

No matter what the disease, an early diagnosis always gives medical personnel more opportunities for treatment and prevention. Nanoparticle Biomarker Tagging (NBT) technology offers powerful capabilities to screen for a wide range of diseases with unprecedented sensitivity that makes detection possible at some of the earliest instances of exposure or infection.

The Ancon Medical NBT device detects biomarkers, which act as chemical signatures for diseases, through the exhaled breath of an individual.

Already, biomarkers for 400 diseases have been discovered. With more funding, researchers can discover even more biomarkers. The Ancon Medical NBT device has potential to be a powerful tool in stopping the spread of diseases in poor and developing countries, making the company a compelling candidate for medical and research grant funding.

Detection of Ebola

The shocking development of the Ebola virus in 2014 shows how crucial early detection of the virus is to prevent its quick spread. Read more >>

Detection of Tuberculosis

Despite being virtually eradicated in developed countries, Tuberculosis is one of the world’s leading causes of death, and a forefront healthcare issue for the developing world. Read more >>

Detection of Cancer

Research has demonstrated that early detection of cancer can save lives, letting patients start treatment before the disease spreads beyond control. Read more >>

Detection of COPD

Chronic obstructive pulmonary disease (COPD) is a lung disease that causes significant breathing issues and is prevalent among smokers and people with significant exposure to airborne toxins like pollution, industrial fumes and asbestos. Read more >>

Ancon Technologies Company Introduction